Adaptive Biotech - ADPT Market Value

Adaptive Biotechnologies (ADPT) strives for dominance in adaptive immune analysis, leveraging advanced sequencing to develop accurate diagnostics and precision therapies. The company's growth relies on the implementation of minimal residual disease tests in clinics and rigorous cost optimization to achieve profitability. This price trend on GURU.Markets, where the market capitalization stands at 4.76, reflects threats from rapid cash burn on innovation and competition from low-cost analysis methods.

ADPT (Adaptive Biotechnologies Corporation) Market Value history from 07/04/2022 to 11/11/2026

Comprehensive metric breakdowns and analytics for Adaptive Biotechnologies Inc. (ADPT)

- current price and projected stock value:

Stock Price Adaptive Biotechnologies Corporation|ADPT - Broker Consensus Forecast

- issuer market value details:

Market Value Adaptive Biotechnologies Inc.|ADPT - Full Business Value

- book value of equity indicators:

Accounting Value per Share Adaptive Biotechnologies|ADPT - Total Net Assets|Market Value to Book Value Ratio adaptivebiotech.com|ADPT - Total Asset Value of Company

- debt burden and liquidity indicators:

Total Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Adaptive Biotechnologies|ADPT - Company Aggregate Debts|Debt to Book Capitalization Ratio Adaptive Biotechnologies Inc.|ADPT - Company Long-Term Loans and Borrowings|Company Short-Term Debt Adaptive Biotechnologies|Quick Ratio adaptivebiotech.com

- net income and valuation multiples indicators:

ADPT - Net Profit|Future Profit Adaptive Biotechnologies|ADPT - Company Value to Net Income|Forward P/E Multiple Adaptive Biotechnologies Corp|ADPT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Inc.|ADPT - Operating profit before deduction of amortization|Earnings per share for the last twelve months Adaptive Biotechnologies|ADPT - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months adaptivebiotech.com|ADPT - Earnings growth in current year|Net earnings per share growth forecast for next year Adaptive Biotechnologies

Fundamental company analysis:ADPT (Adaptive Biotechnologies Corporation)

Product sample of Adaptive Biotechnologies Inc.

Market capitalization reflects the aggregate value of all shares, combining the current share price with the total number of issued securities to gauge market expectations. By analyzing the market capitalization of Adaptive Biotechnologies (ADPT), an investor can discern the asset's sensitivity to risks associated with reductions in partner funding for immune sequencing and the high costs incurred by Adaptive Biotechnologies (ADPT) in developing new diagnostic tests.

Key competitors